Urinary UMOD excretion and chronic kidney disease in gout patients: cross-sectional case-control study

Chien-Hsing Wu1, Chien-Te Lee, Chih-Hsiung Lee

  • 1Division of Nephrology, Chang Gung Memorial Hospital--Kaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung, Taiwan.

Renal Failure
|February 22, 2011
PubMed

Insights

Urinary uromodulin (UMOD) levels are lower in gout patients with chronic kidney disease (CKD). Lower UMOD excretion is linked to reduced kidney function in gout patients, suggesting UMOD

Area of Science:

  • Nephrology
  • Rheumatology
  • Biochemistry

Background:

  • Gout and chronic kidney disease (CKD) frequently coexist, but their relationship remains poorly understood.
  • Previous research suggests a link between diminished urinary uromodulin (UMOD) excretion and CKD in patients with diabetes and lupus.

Purpose of the Study:

  • To investigate the association between urinary UMOD excretion and the presence of CKD in patients diagnosed with gout.

Main Methods:

  • Study included 53 Taiwanese gout patients with stable disease activity, categorized into CKD (n=25) and non-CKD (n=28) groups.
  • Pearson correlation analysis assessed the relationship between urinary UMOD excretion and estimated glomerular filtration rate (eGFR).
  • Multivariate analysis examined factors associated with CKD in gout patients, including urinary UMOD levels, age, and uric acid.

Main Results:

  • Urinary UMOD excretion showed a significant positive correlation with eGFR (p=0.004).
  • Patients with both gout and CKD exhibited lower urinary UMOD excretion compared to those with gout alone (OR: 0.826, p<0.001).
  • Older age and higher uric acid levels were significantly associated with the presence of CKD in gout patients (p<0.001 for both).

Conclusions:

  • This study suggests that uromodulin may play a role in the complex relationship between gout and chronic kidney disease.
  • Lower urinary UMOD excretion is a potential biomarker for CKD in gout patients.
  • Further research, including animal models, is warranted to elucidate the mechanistic link between UMOD, gout, and CKD.

Related Concept Videos

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
Urine Studies I: Urinalysis01:29

Urine Studies I: Urinalysis

Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Urinary Tract Calculi V: Nursing Management01:28

Urinary Tract Calculi V: Nursing Management

AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...